Insights on Discovery

  1. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

  2. Multiplex Imaging 3/24/2025

    Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

  3. Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody 3/24/2025

    Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

  4. Minimize Off-Target Effects With Precision Genome Editing 3/20/2025

    On the path to successfully delivering a safe and efficacious gene editing therapy to patients, drug sponsors must leverage a robust arsenal of tools to mitigate off-target effects on the genome. Said tools include in silico prediction software, especially those that consider epigenetic features when predicting off-target effects.

  5. Navigating The Evolving Landscape Of Immunotherapy in Oncology 3/17/2025

    Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.

  6. Assessment Of Compound Toxicity Effects With High-Content Imaging 3/17/2025

    3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

  7. Automation Of 3D Intestinal Organoids Culture 3/17/2025

    Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

  8. Automating High-Throughput Screens Using Patient-Derived Organoids 3/17/2025

    Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

  9. The Future Promise Of Advanced Therapies In Ophthalmology 3/17/2025

    Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.

  10. Automated Testing For Compound Toxicity Effects 3/17/2025

    Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.